Search Results for “EU” – Page 380 – media

FDA OKs Genentech’s Gazyva for Untreated Follicular Lymphoma

Twice on Thursday, Genentech, scored two approvals from the U.S. Food and Drug Administration(FDA) – a new medicine for hemophilia and an expansion for its cancer drug Gazyva.
- Source: Biospace
- 595
- November 21, 2017
cancer FDA hemophilia lymphoma New Approvals
Japan’s PeptiDream Bags $1.11B+ R&D Pact With Bayer

Peptidream Inc. has scored another billion dollar-plus agreement to develop peptide-based therapies aimed at the treatment multiple disease targets.
- Source: Biospace
- 505
- November 21, 2017
Market Views PDC PDPS peptide-based
UNAIDS announces nearly 21 million people living with HIV now on treatment

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy. By June 2017, around 20.9 million people had access to the life-saving medicines. Such a dramatic scale-up could not have happened without the courage and determination of people living with HIV demanding and claiming their rights, backed up by steady, strong leadership and financial commitment.
- Source: reliefweb
- 446
- November 21, 2017
antiretroviral HIV UNAIDS
Ddu attended MEDICA in Germany

MEDICA is the main attraction for all those involved in the health care industry. With its numerous special events, international conferences and forum programs, not to mention the largest and most comprehensive product display in the industry, MEDICA is the hub for international medical trade.
- Source: Ddu
- 1,129
- November 21, 2017
Exhibitions & Activities MEDICA RFQ
Bird Flu Is Spreading in Asia, Experts (Quietly) Warn

Since October 2016, China has seen a “fifth wave” of H7N9 infections. Nearly 1,600 people have tested positive, almost 40 percent of whom have died.
- Source: Postnewsreport
- 569
- November 21, 2017
bird flu China H7N9 Researches
Psychedelics and Psychotherapy–Is There a Role for MDMA in the Treatment of PTSD?

In a recent study, scientists investigate the use of MDMA in conjunction with psychotherapy as an aid in treating and alleviating PTSD symptoms.
- Source: medicalnewsbulletin
- 465
- November 20, 2017
psychotherapy PTSD symptom Researches
What if clients ask me to send samples?

Sending samples may not sound like be a big deal for most people engaged in the medical trade but do you really know how to do it correctly? Today, Ddu will share our tips on effective sample delivery.
- Source: Ddu
- 642
- November 17, 2017
Ddu College sample delivery
Ddu College-China’s Import and Export Market Report of Respiratory System Drugs

Respiratory system drugs is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia. Today, Ddu, the leading global pharmaceutical & medical device B2B online platform, will share China’s Import and Export Market Report of Respiratory System Drugs with you.
- Source: Ddu
- 1,316
- November 17, 2017
asthma COPD Ddu College pneumonia respiratory
Clinical trial shows treatment is ‘transformative’ for babies with spinal muscular atrophy

Infants with the most severe form of spinal muscular atrophy (SMA) were more likely to show gains in motor function and were 47 percent more likely to survive without permanent assisted ventilation support when treated with a new medication, according to a study published today in the New England Journal of Medicine. The drug, nusinersen, performed so well that the study was stopped early and the treatment was approved shortly thereafter by the U.S. Food and Drug Administration (FDA) for all patients with this progressive neuromuscular disorder.
- Source: sciencedaily
- 453
- November 17, 2017
Market Views neuromuscular disorder SMA
Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell Therapy Has Been Granted Breakthrough Therapy Designation

Celgene Corporation and bluebird bio, Inc. announced that bb2121, a chimeric antigen receptor T-cell (CAR-T) therapy targeting b-cell maturation antigen (BCMA) in previously treated patients with multiple myeloma, has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) and PRIority MEdicines (PRIME) eligibility by the European Medicines Agency (EMA).
- Source: ansa.it
- 590
- November 17, 2017
BTD CAR-T therapy Company Insight

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.